InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,033.26
(
0.30%
)
US TECH 100
16,992.40
(
0.78%
)
Dow Jones
38,026.82
(
0.33%
)
Brent Oil
83.39
(
-0.19%
)
Bitcoin
59,050.57
(
1.40%
)
Post# of 183
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Badger2

Send PM Follow Ignore
Followers 5
Posts 89
Boards Moderated 0
Alias Born 03/21/2014

Badger2

Re: fam401 post# 149

Thursday, 05/01/2014 12:31:34 PM

Thursday, May 01, 2014 12:31:34 PM

Post# of 183
IMO, it is very good. They are on a fast track "Priority Review" per FDA. This means the FDA feels there is an urgent need for their product. I am watching and not in yet. Would like to get a better deal. That may not happen. Good luck!
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!